Clinical trial
A Compliance Improvement Project to Reduce Central Line Associated Blood Stream Infection (CLABSI) Using a Passive Disinfection Device in an Adult Oncological Hospital in Brazil
NCT03391960 is registered in ClinicalTrials.gov with Solventum US LLC as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Compliance Improvement Project to Reduce Central Line Associated Blood Stream Infection (CLABSI) Using a Passive Disinfection Device in an Adult Oncological Hospital in Brazil
- Lead sponsor
- Solventum US LLC
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- April 1, 2018
- Completion date
- October 31, 2018
- Enrollment
- 165 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
infection, hospital